223 related articles for article (PubMed ID: 19140823)
21. Time-dependent events in natural history of occult hepatitis B virus infection: the importance of population-based long-term follow-up study with repeated measurements.
Chen CJ
J Hepatol; 2005 Apr; 42(4):438-40. PubMed ID: 15763321
[No Abstract] [Full Text] [Related]
22. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
23. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection].
Shang QH; Yu JG; Xu CZ; An Y; Liu FY; Sun SC; Zhang GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):440-2. PubMed ID: 19544639
[TBL] [Abstract][Full Text] [Related]
24. [Progresses in the molecular diagnosis of hepatitis B viral infection].
Panait M; Oprişan G; Codiţă I
Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
[No Abstract] [Full Text] [Related]
25. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
Caruntu FA; Gheorghita V
J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
[No Abstract] [Full Text] [Related]
26. [The correlation of serum DNA level of the chronic hepatitis B and the clinical significance].
Mei XP; Li J; Zeng Y; Xiong LS; Chang MH; Tan CX
Zhonghua Gan Zang Bing Za Zhi; 2004 May; 12(5):313. PubMed ID: 15161520
[No Abstract] [Full Text] [Related]
27. Sexual transmission of viral hepatitis B and its carrier state in patients with sexually transmitted diseases (STD).
Dutta RK; Sachdeva SM
J Assoc Physicians India; 1982 Dec; 30(12):861-4. PubMed ID: 6897866
[No Abstract] [Full Text] [Related]
28. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331
[TBL] [Abstract][Full Text] [Related]
29. Pooled hepatitis B virus DNA testing by nucleic acid amplification: implementation or not.
Stramer SL
Transfusion; 2005 Aug; 45(8):1242-6. PubMed ID: 16078908
[No Abstract] [Full Text] [Related]
30. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers.
Elefsiniotis IS; Papadakis M; Vlahos G; Daskalakis G; Saroglou G; Antsaklis A
Intervirology; 2009; 52(3):132-4. PubMed ID: 19468236
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of occult hepatitis B cases in Greek blood donors.
Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
[TBL] [Abstract][Full Text] [Related]
33. [Changes of peripheral blood B lymphocyte subsets in chronic hepatitis B patients and chronic asymptomatic HBV carriers].
Qin HG; Yan YC; Wu XF; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):773-4. PubMed ID: 17064476
[No Abstract] [Full Text] [Related]
34. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
[TBL] [Abstract][Full Text] [Related]
35. Does hepatitis B surface antigen kinetics, including both decline and reaching a threshold, improve prediction of response?
Wiegand J; Patel K; Tillmann HL
Hepatology; 2009 Oct; 50(4):1314; author reply 1314. PubMed ID: 19676132
[No Abstract] [Full Text] [Related]
36. Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.
Borgniet O; Parvaz P; Bouix C; Chevallier P; Trépo C; André P; Zoulim F
J Med Virol; 2009 Aug; 81(8):1336-42. PubMed ID: 19551826
[TBL] [Abstract][Full Text] [Related]
37. Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV.
Di Stefano M; Volpe A; Stallone G; Tartaglia L; Prato R; Martinelli D; Pastore G; Gesualdo L; Fiore JR
J Nephrol; 2009; 22(3):381-6. PubMed ID: 19557715
[TBL] [Abstract][Full Text] [Related]
38. Viral hepatitis in HIV infection.
Leiner S
N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17615640
[No Abstract] [Full Text] [Related]
39. HBV-DNA in hemodialysis patients infected by HCV.
Arababadi MK; Hassanshahi G; Yousefi H
Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
[TBL] [Abstract][Full Text] [Related]
40. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
